I became so overwhelmed by covering COVID-19 that I no longer had time to post individual stories. So here are links to my latest stories…
Comments closedCategory: Science
The United States government routinely sues pharmaceutical companies for making false claims, bilking Medicare, illegal kickbacks, and sloppy manufacturing practices. But on 6 November, the…
Comments closedAn experimental dengue vaccine has shown promising early results in a large, multicountry trial, but critical questions remain about its effectiveness and safety. Still unclear,…
Comments closedA 66% price slash of a little used but powerful drug that prevents tuberculosis (TB) could help stave off the deadly lung disease in millions…
Comments closedBy Jon Cohen, Jocelyn Kaiser Two major U.S. biomedical research funders plan to each put at least $100 million over 4 years toward bringing cutting-edge, gene-based treatments…
Comments closedThis story was supported by the Pulitzer Center. On a lightly snowing Sunday evening, a potential participant in Denis Rebrikov’s controversial plans to create gene-edited babies meets…
Comments closedThis story was supported by the Pulitzer Center. Earlier this month, Denis Rebrikov went to an old mansion in Moscow that now houses the Russian…
Comments closedCRISPR, an extraordinarily powerful genome-editing tool invented in 2012, can still be clumsy. It sometimes changes genes it shouldn’t, and it edits by hacking through…
Comments closedIn the past decade, increasingly powerful genetic techniques have found hordes of microbial DNA in everything from the human gut to a scoop of seawater.…
Comments closed